We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for etranacogene dezaparvovec (CSL Behring Australia Pty Ltd)
Active ingredients
etranacogene dezaparvovec
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
For the treatment of haemophilia B
Therapeutic area
Haematology